Rubicon Research Limited (RUBICON) — Announcement | 10 June 2026
No summary available
About Rubicon Research Limited (RUBICON)
Healthcare · Pharmaceuticals · Listed on NSE
📡 Get AI alerts when RUBICON files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track RUBICON — Free💡 Ask AI about this filing
📊 More RUBICON filings
- Announcement — 28 September 2026Rubicon Research Limited announced that its trading window will close on October 1, 2026, ahead of t...
- 🔴 Insider Trading — 29 August 2026Rubicon Research disclosed a promoter stake sale of 1.4 million shares to General Atlantic Singapore...
- 🔴 Insider Trading — 27 August 2026Rubicon Research Limited disclosed that General Atlantic Singapore RR Pte. Ltd., its promoter, sold ...
- 🟡 Board Meeting — 26 August 2026Rubicon Research Limited held its 27th Annual General Meeting on August 26, 2026, via video conferen...
- 🔴 Financial Results — 19 August 2026Rubicon Research reported Q1 FY27 revenue of **₹534 crores**, up **51% YoY**, with EBITDA at **₹131 ...
🔥 Also filed on 10 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when RUBICON files new disclosures
Track RUBICON filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track RUBICON — FreeFree account · 2 AI queries/day